Region and sex differences in constituent dopamine neurons and immunoreactivity for intracellular estrogen and androgen receptors in mesocortical projections in rats.
Many cortical and prefrontal functions show sex differences in their development, adult capacity, and dysfunction in disorders like schizophrenia. Correlations between circulating gonadal hormones and certain prefrontal functions have also been identified in humans and experimental animal models. Although multiple mechanisms may be involved, such hormone sensitivities/sex differences could be related to gonadal steroid actions on another regulator of cortical/prefrontal cortical function, the mesocortical dopamine system. Thus, although it is well known that perturbations in prefrontal dopamine signaling induce behavioral deficits, it is also known that several endpoints of these afferents are sensitive to gonadal steroids and/or are sexually dimorphic. This study explored possible substrates for this in two ways: by comparing the distributions of immunoreactivity for intracellular estrogen (alpha and beta) and androgen receptors among retrogradely labeled dopaminergic and nondopaminergic mesocortical neurons projecting to prefrontal, premotor, and primary motor cortices, areas in which male rat dopamine axons are differentially hormone-sensitive; and by comparing anatomical data in males and females. These analyses revealed region-, cell-, and sex-specific specializations in receptor localization that paralleled established patterns of mesocortical hormone sensitivity, including the androgen sensitivity of dopamine axons and dopamine-dependent functions in prefrontal cortex. It was also found that the proportions of dopamine neurons making up mesocortical projections were approximately 30% in males, whereas in females, significantly more constituent cells were dopaminergic. Together, these features may be part of the neurobiology giving mesocortical afferents their hormone sensitivities and/or sex differences in physiology, function, and dysfunction in disease.
Kritzer
Mary F
MF
Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York 11794-5230, USA. mkritzer@notes.cc.sunysb.edu
Creutz
Lela M
LM
D000818:Animals; D002540:Cerebral Cortex / Q000166:cytology / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D047628:Estrogen Receptor alpha / Q000378:metabolism; D047629:Estrogen Receptor beta / Q000378:metabolism; D004967:Estrogens / Q000378:metabolism; D005260:Female; D007150:Immunohistochemistry; D008297:Male; D008636:Mesencephalon / Q000166:cytology / Q000378:metabolism*; D009044:Motor Cortex / Q000166:cytology / Q000378:metabolism; D009434:Neural Pathways / Q000166:cytology / Q000378:metabolism; D009474:Neurons / Q000378:metabolism*; D017397:Prefrontal Cortex / Q000166:cytology / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011944:Receptors, Androgen / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000378:metabolism*; D012727:Sex Characteristics; D013378:Substantia Nigra / Q000166:cytology / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism; D017557:Ventral Tegmental Area / Q000166:cytology / Q000378:metabolism
D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D004967:Estrogens; D011944:Receptors, Androgen; D011960:Receptors, Estrogen; D013739:Testosterone; D004298:Dopamine
Arch Sex Behav. 2008 Feb;37(1):100-11
18074217
Horm Behav. 2007 May;51(5):587-96
17433328
Horm Behav. 2007 Feb;51(2):183-94
16942768
Brain Res. 1991 Dec 24;568(1-2):325-9
1726070
Psychopharmacology (Berl). 2003 Nov;170(3):294-300
12898124
Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1325-9
8577763
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2938-42
16477003
Behav Neurosci. 1996 Aug;110(4):673-84
8864260
J Neurosci. 2002 Aug 15;22(16):7225-33
12177217
Cereb Cortex. 2003 Mar;13(3):282-96
12571118
J Child Psychol Psychiatry. 1989 Sep;30(5):671-89
2793956
Neurosci Biobehav Rev. 2003 Oct;27(6):555-79
14599436
J Comp Neurol. 1985 Nov 15;241(3):253-67
2418068
J Comp Neurol. 1979 Sep 1;187(1):85-98
489779
Ann N Y Acad Sci. 2004 Dec;1032:291-4
15677432
J Neurosci. 1997 Nov 1;17(21):8528-35
9334425
Brain Res. 1978 Feb 17;142(1):1-24
626911
J Child Neurol. 1993 Jan;8(1):64-72
8445173
J Neurosci. 2003 Aug 20;23(20):7569-76
12930795
J Neurosci. 2005 Jun 8;25(23):5553-62
15944383
Br J Cancer. 2003 Sep 15;89(6):971-6
12966411
Neuroscience. 1984 Feb;11(2):425-35
6201780
Psychol Med. 1990 Feb;20(1):89-94
2320701
J Neurobiol. 2000 Apr;43(1):64-78
10756067
J Comp Neurol. 1993 May 15;331(3):297-309
8514911
Psychoneuroendocrinology. 2004 Sep;29(8):1019-27
15219653
Indian J Med Sci. 2004 Jan;58(1):3-9
14960795
Cancer. 2005 Apr 1;103(7):1381-7
15717315
Brain Cogn. 1990 Sep;14(1):26-43
2223043
Schizophr Bull. 1990;16(2):185-94
2197713
Behav Neurosci. 1997 Apr;111(2):369-80
9106676
J Comp Neurol. 1982 Nov 20;212(1):76-88
6294151
Brain Res. 1994 May 16;646(1):157-60
8055334
Horm Behav. 2008 Aug;54(2):244-52
18511051
Dev Psychobiol. 1981 Sep;14(5):425-38
7274582
Horm Behav. 1998 Apr;33(2):85-94
9647934
Brain Res Bull. 1990 Mar;24(3):341-54
2337814
J Neurosci. 1996 Jan;16(1):373-9
8613804
Horm Behav. 2005 Sep;48(3):268-77
15890350
Physiol Behav. 2008 Feb 27;93(3):595-605
18031771
Horm Behav. 2001 Mar;39(2):167-74
11243744
Psychoneuroendocrinology. 2000 Aug;25(6):563-75
10840169
Behav Brain Funct. 2006 Mar 07;2:8
16522198
Brain Res Bull. 1982 Jul-Dec;9(1-6):321-53
6816390
J Neurosci Res. 2003 Dec 1;74(5):637-43
14635215
J Clin Endocrinol Metab. 2006 May;91(5):1683-90
16478814
Neurosci Biobehav Rev. 1990 Spring;14(1):23-33
2183097
J Comp Neurol. 1990 Apr 8;294(2):262-80
2332532
Behav Neurosci. 1989 Dec;103(6):1287-95
2610921
Brain Res. 1996 Feb 26;710(1-2):69-78
8963680
J Comp Neurol. 1997 Mar 10;379(2):247-60
9050788
Schizophr Res. 2002 Nov 1;58(1):69-74
12363392
Neural Netw. 2002 Jun-Jul;15(4-6):561-72
12371512
Schizophr Res. 2006 Jun;84(2-3):405-10
16545544
Brain Res Bull. 1988 Mar;20(3):333-48
2452673
Child Dev. 1985 Aug;56(4):868-83
4042750
Behav Brain Res. 1981 Jul;3(1):125-30
7248063
Cereb Cortex. 2002 Feb;12(2):116-28
11739260
Synapse. 2000 Nov;38(2):114-23
11018785
J Androl. 2003 Jul-Aug;24(4):568-76
12826696
Psychoneuroendocrinology. 1991;16(1-3):177-88
1961838
Psychoneuroendocrinology. 1991;16(4):323-34
1745699
Cereb Cortex. 1991 Jul-Aug;1(4):273-92
1668366
Brain Res. 1999 Sep 11;841(1-2):43-52
10546986
J Comp Neurol. 2004 Aug 30;476(4):348-62
15282710
Psychiatry Res. 1996 Sep 27;64(2):105-14
8912952
J Neurocytol. 2003 Feb;32(2):131-41
14707548
Annu Rev Neurosci. 1978;1:129-69
756202
Arch Neurol. 1985 May;42(5):428-59
3994562
J Comp Neurol. 2002 May 20;447(1):1-7
11967890
Psychoneuroendocrinology. 2005 Jan;30(1):111-4
15358449
J Neurophysiol. 2000 Mar;83(3):1733-50
10712493
Behav Brain Res. 2001 Aug 27;123(1):65-76
11377730
Pharmacol Biochem Behav. 2004 Jul;78(3):559-68
15251265
Psychoneuroendocrinology. 2004 Jun;29(5):612-7
15041084
Mol Psychiatry. 2004 May;9(5):531-8
14569273
J Comp Neurol. 2002 May 6;446(3):288-300
11932944
J Comp Neurol. 1983 Jul 10;217(4):390-404
6886060
Trends Cogn Sci. 2006 Feb;10(2):77-82
16386941
Q J Exp Psychol. 1980 Aug;32(3):473-89
7422819